Roche
Roche’s cholesterol-lowering drug candidate shows promise in fighting prostate cancer
April 15, 2016Medical Communications, Research and Development RO 48-9071, Roche, cholesterol, drug, missouri, oncology, university
Researchers from the University of Missouri have found that a compound developed by Roche Pharmaceuticals for the treatment of high …
Roche’s Venclexta gets accelerated approval from US FDA for chronic lymphocytic leukemia
April 12, 2016Manufacturing and Production, Research and Development, Sales and Marketing AbbVie, Roche, US FDA, Venclexta, chronic lymphocytic leukemia
Swiss drug firm Roche (SIX: ROG) on Tuesday said the US Food and Drug Administration (FDA) has granted accelerated approval …
Roche’s cancer immunotherapy for lung cancer gets US FDA priority review
April 11, 2016Business Services, Research and Development, Sales and Marketing Roche, US FDA, atezolizumab, lung cancer
Swiss drug firm Roche (SIX: ROG) on Monday said the US Food and Drug Administration (FDA) has accepted its Biologics …
Roche to initiate testing for Zika virus under FDA investigational new drug application approval
March 31, 2016Manufacturing and Production, Research and Development Roche, Zika
Roche (SWX: RO) has announced that the US Food and Drug Administration (FDA) has provided approval to initiate the collection …
Darzalex to be trialled in combination with atezolizumab in multiple myeloma and solid tumours
March 22, 2016Research and Development Genentech, Genmab, Janssen, Roche, atezolizumab, clnical trials, multiple myeloma, phase ib, solid tumours, tumour
Phase Ib clinical studies are set to begin, which will evaluate Darzalex (daratumumab) in combination with atezolizumab in a solid …
Kite Pharma, Roche to co-develop two new treatments for non-hodgkin lymphoma
March 18, 2016Medical Communications, Research and Development Gentech, Roche, kite pharma, non-Hodgkin lymphoma
Kite Pharma (Nasdaq: KITE) said it will collaborate with Swiss drug major Roche (SIX: ROG) to evaluate the safety and efficacy …
Blueprint Medicines agrees $1 billion-plus deal with Roche for cancer therapy
March 16, 2016Business Services, Research and Development, Sales and Marketing Blueprint Medicines, Deals, Immunokinases, Roche, drug development
Blueprint Medicines Corp (Nasdaq: BPMC) said it has signed an over $1 billion deal with oncology drug giant Roche (SIX: ROG) …
Cellnovo, Roche sign deal to integrate diabetes platforms
March 15, 2016Manufacturing and Production, Sales and Marketing Cellnovo, Roche, diabetes
Cellnovo Group (Paris: CLNV) on Tuesday said it has signed a deal with Swiss drug major Roche (Euronext: ROG) to …
Genentech cancer immunotherapy gets Priority FDA Review in bladder cancer
March 15, 2016Manufacturing and Production, Research and Development FDA, Genentech, Roche, atezolizumab, bladder cancer, priority review
The US FDA has granted Roche subsidiary Genentech a Priority Review for atezolizumab in treating advanced bladder cancer, whose disease …
Two-drug combo shown to significantly shrink breast cancer in days
March 10, 2016Medical Communications, Research and Development GSK, Herceptin, Novartis, Roche, Tyverb
Results of a clinical trial have revealed that Novartis’ Tyverb (lapatinib), in combination with Roche’s Herceptin (trastuzumab), can significantly shrink …
Roche finds contradictory results in identical Phase III asthma trials
February 29, 2016Manufacturing and Production, Research and Development Roche, lebrikizumab asthma
Roche has reported contradictory results from two identical Phase III studies of lebrikizumab in severe asthma, with one showing the …
Boehringer launches IPF initiatives
February 29, 2016Medical Communications, Research and Development, Sales and Marketing Boehringer Ingelheim, Esbriet, Roche, idiopathic pulmonary fibrosis, ofev
Boehringer Ingelheim has launched a collaborative initiative aimed at raising awareness and understanding of the rare lung disease Idiopathic Pulmonary …
FDA gives Roche MS drug breakthrough status
February 17, 2016Research and Development Genentech, MS, Roche
Roche subsidiary Genentech has been awarded US Food and Drug Administration (FDA) Breakthrough Therapy Designation for its drug Ocrevus (ocrelizumab) …
New HR head as Roche makes corporate executive committee changes
January 28, 2016Medical Communications Roche
The Board of Directors has appointed Cristina Wilbur to succeed Silvia Ayyoubi as head of group human resources and member …
Roche beats estimates with strong 2015 sales
January 28, 2016Medical Communications, Sales and Marketing Esbriet, Herceptin, Roche, avastin
Roche reported full-year financial results today, beating analysts’ estimates, with the Swiss drugmaker announcing Group sales increases for 2015 in …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
